Smoking Cessation Products Comprehensive Study by Type (Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride, Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler), E-Cigarette), Sales Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), End User (Adults, Teenagers) Players and Region - Global Market Outlook to 2030

Smoking Cessation Products Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Smoking Cessation Products Market Scope
The smoking cessation products are the products that are developed to help quit or at least reduce the addiction to smoking. The various health-related concerns, increasing the desire to quit smoking is expected to increase the smoking cessation product market. The rising consumption of smoking and tobacco among teenagers is raising concerns resulting in stringent regulatory norms about smoking products, due to which smoking cessation product market will continue to rise during the forecasted year. The use of cigarette remains the leading cause of preventable death in the United States, marking an estimated 480,000 lives or more each year. Although cigarette use in the United States continues to decline, according to the Centers for Disease Control and Prevention (CDC), 34.2 million American adults smoked cigarettes every day or some days in 2018, and nearly 1.2 million American middle and high school students smoked cigarettes in the past 30 days in 2019.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledGlaxoSmithKline plc (United Kingdom), Pfizer Inc. (United States), Johnson & Johnson (United States), Reynolds American, Inc. (United States), Cipla Inc. (India), Imperial Brands (United Kingdom), Perrigo Company plc, (Ireland) and Amarantus Bioscience Holdings, Inc. (United States)
CAGR%


Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Smoking Cessation Products market throughout the predicted period.

GlaxoSmithKline plc (United Kingdom), Pfizer Inc. (United States), Johnson & Johnson (United States), Reynolds American, Inc. (United States), Cipla Inc. (India), Imperial Brands (United Kingdom), Perrigo Company plc, (Ireland) and Amarantus Bioscience Holdings, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Takeda Consumer Healthcare Company Limited (Japan) and Kimree Technology Co.,Ltd. (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Smoking Cessation Products market by Type and Region with country level break-up.

On the basis of geography, the market of Smoking Cessation Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In June 2019, Amarantus Bioscience Holdings Inc., the company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics announced that it entered the letter of intent ('LOI') with the Alchemist's Kitchen a plant-based company to establish a joint venture for commercialization of hemp-based herbal smokable products ‘Herbal Smokes’ for Addiction Treatment Including Smoking Cessation.
In November 2019, Witi, a technology company building AI-powered, medical-grade vaporization devices, announced a partnership with Perrigo Company plc, to license Witi’s patent-pending hardware and software IP in development of a new, inventive smoking cessation product. The two companies will develop an Electronic Nicotine Delivery System (ENDS), that if successful, would be submitted for approval by the US Food and Drug Administration (FDA) and other international regulatory agencies.


Influencing Trend:
Increasing Consumption of Gums and E-Cigarette and The Emergence of Various Flavoured Smoking Cessation Products

Market Growth Drivers:
The Growing Population Including Teenagers with Addiction to Smoking and Tobacco Leading to Higher Chances of Lungs Related Problems and Awareness about the Harmful Effects of Smoking Addiction and Desire to Quit Smoking

Challenges:
High Cost of Smoking Cessation Products and Treatment and Need for Frequent Dosing of Smoking Cessation Products

Restraints:
Risk of Side Effects Associated with Consumption of Smoking Cessation Products

Opportunities:
Stringent Regulatory Guidelines and Standard Regarding Consumption of Smoking Products will Boost the Smoking Cessation Products and Introducing Various Smoking Treatment Program

Key Target Audience
Smoking Cessation Products Manufacturers, Smoking Cessation Products International Traders, Smoking Cessation Products Distributors and Suppliers, Regulatory Bodies, Potential Investors, Research and Development Institutes, Upstream and Downstream Buyers and Others

Report Objectives / Segmentation Covered

By Type
  • Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride
  • Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler)
  • E-Cigarette
By Sales Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

By End User
  • Adults
  • Teenagers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing Population Including Teenagers with Addiction to Smoking and Tobacco Leading to Higher Chances of Lungs Related Problems
      • 3.2.2. Awareness about the Harmful Effects of Smoking Addiction and Desire to Quit Smoking
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Smoking Cessation Products and Treatment
      • 3.3.2. Need for Frequent Dosing of Smoking Cessation Products
    • 3.4. Market Trends
      • 3.4.1. Increasing Consumption of Gums and E-Cigarette
      • 3.4.2. The Emergence of Various Flavoured Smoking Cessation Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Smoking Cessation Products, by Type, Sales Channel, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Smoking Cessation Products (Value)
      • 5.2.1. Global Smoking Cessation Products by: Type (Value)
        • 5.2.1.1. Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride
        • 5.2.1.2. Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler)
        • 5.2.1.3. E-Cigarette
      • 5.2.2. Global Smoking Cessation Products by: Sales Channel (Value)
        • 5.2.2.1. Online Pharmacies
        • 5.2.2.2. Hospital Pharmacies
        • 5.2.2.3. Retail Pharmacies
      • 5.2.3. Global Smoking Cessation Products by: End User (Value)
        • 5.2.3.1. Adults
        • 5.2.3.2. Teenagers
      • 5.2.4. Global Smoking Cessation Products Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Smoking Cessation Products (Volume)
      • 5.3.1. Global Smoking Cessation Products by: Type (Volume)
        • 5.3.1.1. Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride
        • 5.3.1.2. Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler)
        • 5.3.1.3. E-Cigarette
      • 5.3.2. Global Smoking Cessation Products by: Sales Channel (Volume)
        • 5.3.2.1. Online Pharmacies
        • 5.3.2.2. Hospital Pharmacies
        • 5.3.2.3. Retail Pharmacies
      • 5.3.3. Global Smoking Cessation Products by: End User (Volume)
        • 5.3.3.1. Adults
        • 5.3.3.2. Teenagers
      • 5.3.4. Global Smoking Cessation Products Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Smoking Cessation Products (Price)
      • 5.4.1. Global Smoking Cessation Products by: Type (Price)
  • 6. Smoking Cessation Products: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Reynolds American, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cipla Inc. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Imperial Brands (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Perrigo Company plc, (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Amarantus Bioscience Holdings, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Smoking Cessation Products Sale, by Type, Sales Channel, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Smoking Cessation Products (Value)
      • 7.2.1. Global Smoking Cessation Products by: Type (Value)
        • 7.2.1.1. Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride
        • 7.2.1.2. Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler)
        • 7.2.1.3. E-Cigarette
      • 7.2.2. Global Smoking Cessation Products by: Sales Channel (Value)
        • 7.2.2.1. Online Pharmacies
        • 7.2.2.2. Hospital Pharmacies
        • 7.2.2.3. Retail Pharmacies
      • 7.2.3. Global Smoking Cessation Products by: End User (Value)
        • 7.2.3.1. Adults
        • 7.2.3.2. Teenagers
      • 7.2.4. Global Smoking Cessation Products Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Smoking Cessation Products (Volume)
      • 7.3.1. Global Smoking Cessation Products by: Type (Volume)
        • 7.3.1.1. Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride
        • 7.3.1.2. Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler)
        • 7.3.1.3. E-Cigarette
      • 7.3.2. Global Smoking Cessation Products by: Sales Channel (Volume)
        • 7.3.2.1. Online Pharmacies
        • 7.3.2.2. Hospital Pharmacies
        • 7.3.2.3. Retail Pharmacies
      • 7.3.3. Global Smoking Cessation Products by: End User (Volume)
        • 7.3.3.1. Adults
        • 7.3.3.2. Teenagers
      • 7.3.4. Global Smoking Cessation Products Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Smoking Cessation Products (Price)
      • 7.4.1. Global Smoking Cessation Products by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Smoking Cessation Products: by Type(USD Million)
  • Table 2. Smoking Cessation Products Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride , by Region USD Million (2018-2023)
  • Table 3. Smoking Cessation Products Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler) , by Region USD Million (2018-2023)
  • Table 4. Smoking Cessation Products E-Cigarette , by Region USD Million (2018-2023)
  • Table 5. Smoking Cessation Products: by Sales Channel(USD Million)
  • Table 6. Smoking Cessation Products Online Pharmacies , by Region USD Million (2018-2023)
  • Table 7. Smoking Cessation Products Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 8. Smoking Cessation Products Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 9. Smoking Cessation Products: by End User(USD Million)
  • Table 10. Smoking Cessation Products Adults , by Region USD Million (2018-2023)
  • Table 11. Smoking Cessation Products Teenagers , by Region USD Million (2018-2023)
  • Table 12. South America Smoking Cessation Products, by Country USD Million (2018-2023)
  • Table 13. South America Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 14. South America Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 15. South America Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 16. Brazil Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 17. Brazil Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 18. Brazil Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 19. Argentina Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 20. Argentina Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 21. Argentina Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 22. Rest of South America Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 24. Rest of South America Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 25. Asia Pacific Smoking Cessation Products, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 28. Asia Pacific Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 29. China Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 30. China Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 31. China Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 32. Japan Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 33. Japan Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 34. Japan Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 35. India Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 36. India Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 37. India Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 38. South Korea Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 39. South Korea Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 40. South Korea Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 41. Taiwan Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 42. Taiwan Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 43. Taiwan Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 44. Australia Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 45. Australia Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 46. Australia Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 50. Europe Smoking Cessation Products, by Country USD Million (2018-2023)
  • Table 51. Europe Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 52. Europe Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 53. Europe Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 54. Germany Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 55. Germany Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 56. Germany Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 57. France Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 58. France Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 59. France Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 60. Italy Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 61. Italy Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 62. Italy Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 63. United Kingdom Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 65. United Kingdom Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 66. Netherlands Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 67. Netherlands Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 68. Netherlands Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 69. Rest of Europe Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 71. Rest of Europe Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 72. MEA Smoking Cessation Products, by Country USD Million (2018-2023)
  • Table 73. MEA Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 74. MEA Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 75. MEA Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 76. Middle East Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 77. Middle East Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 78. Middle East Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 79. Africa Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 80. Africa Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 81. Africa Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 82. North America Smoking Cessation Products, by Country USD Million (2018-2023)
  • Table 83. North America Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 84. North America Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 85. North America Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 86. United States Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 87. United States Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 88. United States Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 89. Canada Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 90. Canada Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 91. Canada Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 92. Mexico Smoking Cessation Products, by Type USD Million (2018-2023)
  • Table 93. Mexico Smoking Cessation Products, by Sales Channel USD Million (2018-2023)
  • Table 94. Mexico Smoking Cessation Products, by End User USD Million (2018-2023)
  • Table 95. Smoking Cessation Products Sales: by Type(K Units)
  • Table 96. Smoking Cessation Products Sales Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride , by Region K Units (2018-2023)
  • Table 97. Smoking Cessation Products Sales Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler) , by Region K Units (2018-2023)
  • Table 98. Smoking Cessation Products Sales E-Cigarette , by Region K Units (2018-2023)
  • Table 99. Smoking Cessation Products Sales: by Sales Channel(K Units)
  • Table 100. Smoking Cessation Products Sales Online Pharmacies , by Region K Units (2018-2023)
  • Table 101. Smoking Cessation Products Sales Hospital Pharmacies , by Region K Units (2018-2023)
  • Table 102. Smoking Cessation Products Sales Retail Pharmacies , by Region K Units (2018-2023)
  • Table 103. Smoking Cessation Products Sales: by End User(K Units)
  • Table 104. Smoking Cessation Products Sales Adults , by Region K Units (2018-2023)
  • Table 105. Smoking Cessation Products Sales Teenagers , by Region K Units (2018-2023)
  • Table 106. South America Smoking Cessation Products Sales, by Country K Units (2018-2023)
  • Table 107. South America Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 108. South America Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 109. South America Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 110. Brazil Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 111. Brazil Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 112. Brazil Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 113. Argentina Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 114. Argentina Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 115. Argentina Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 116. Rest of South America Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 117. Rest of South America Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 118. Rest of South America Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 119. Asia Pacific Smoking Cessation Products Sales, by Country K Units (2018-2023)
  • Table 120. Asia Pacific Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 121. Asia Pacific Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 122. Asia Pacific Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 123. China Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 124. China Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 125. China Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 126. Japan Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 127. Japan Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 128. Japan Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 129. India Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 130. India Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 131. India Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 132. South Korea Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 133. South Korea Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 134. South Korea Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 135. Taiwan Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 136. Taiwan Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 137. Taiwan Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 138. Australia Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 139. Australia Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 140. Australia Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 141. Rest of Asia-Pacific Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 142. Rest of Asia-Pacific Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 143. Rest of Asia-Pacific Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 144. Europe Smoking Cessation Products Sales, by Country K Units (2018-2023)
  • Table 145. Europe Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 146. Europe Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 147. Europe Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 148. Germany Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 149. Germany Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 150. Germany Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 151. France Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 152. France Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 153. France Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 154. Italy Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 155. Italy Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 156. Italy Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 157. United Kingdom Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 158. United Kingdom Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 159. United Kingdom Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 160. Netherlands Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 161. Netherlands Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 162. Netherlands Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 163. Rest of Europe Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 164. Rest of Europe Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 165. Rest of Europe Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 166. MEA Smoking Cessation Products Sales, by Country K Units (2018-2023)
  • Table 167. MEA Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 168. MEA Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 169. MEA Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 170. Middle East Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 171. Middle East Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 172. Middle East Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 173. Africa Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 174. Africa Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 175. Africa Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 176. North America Smoking Cessation Products Sales, by Country K Units (2018-2023)
  • Table 177. North America Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 178. North America Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 179. North America Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 180. United States Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 181. United States Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 182. United States Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 183. Canada Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 184. Canada Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 185. Canada Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 186. Mexico Smoking Cessation Products Sales, by Type K Units (2018-2023)
  • Table 187. Mexico Smoking Cessation Products Sales, by Sales Channel K Units (2018-2023)
  • Table 188. Mexico Smoking Cessation Products Sales, by End User K Units (2018-2023)
  • Table 189. Smoking Cessation Products: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Smoking Cessation Products: by Type(USD Million)
  • Table 199. Smoking Cessation Products Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride , by Region USD Million (2025-2030)
  • Table 200. Smoking Cessation Products Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler) , by Region USD Million (2025-2030)
  • Table 201. Smoking Cessation Products E-Cigarette , by Region USD Million (2025-2030)
  • Table 202. Smoking Cessation Products: by Sales Channel(USD Million)
  • Table 203. Smoking Cessation Products Online Pharmacies , by Region USD Million (2025-2030)
  • Table 204. Smoking Cessation Products Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 205. Smoking Cessation Products Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 206. Smoking Cessation Products: by End User(USD Million)
  • Table 207. Smoking Cessation Products Adults , by Region USD Million (2025-2030)
  • Table 208. Smoking Cessation Products Teenagers , by Region USD Million (2025-2030)
  • Table 209. South America Smoking Cessation Products, by Country USD Million (2025-2030)
  • Table 210. South America Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 211. South America Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 212. South America Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 213. Brazil Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 214. Brazil Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 215. Brazil Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 216. Argentina Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 217. Argentina Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 218. Argentina Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 219. Rest of South America Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 220. Rest of South America Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 221. Rest of South America Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 222. Asia Pacific Smoking Cessation Products, by Country USD Million (2025-2030)
  • Table 223. Asia Pacific Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 224. Asia Pacific Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 225. Asia Pacific Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 226. China Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 227. China Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 228. China Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 229. Japan Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 230. Japan Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 231. Japan Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 232. India Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 233. India Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 234. India Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 235. South Korea Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 236. South Korea Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 237. South Korea Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 238. Taiwan Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 239. Taiwan Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 240. Taiwan Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 241. Australia Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 242. Australia Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 243. Australia Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 244. Rest of Asia-Pacific Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 247. Europe Smoking Cessation Products, by Country USD Million (2025-2030)
  • Table 248. Europe Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 249. Europe Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 250. Europe Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 251. Germany Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 252. Germany Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 253. Germany Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 254. France Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 255. France Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 256. France Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 257. Italy Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 258. Italy Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 259. Italy Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 260. United Kingdom Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 261. United Kingdom Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 262. United Kingdom Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 263. Netherlands Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 264. Netherlands Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 265. Netherlands Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 266. Rest of Europe Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 267. Rest of Europe Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 268. Rest of Europe Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 269. MEA Smoking Cessation Products, by Country USD Million (2025-2030)
  • Table 270. MEA Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 271. MEA Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 272. MEA Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 273. Middle East Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 274. Middle East Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 275. Middle East Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 276. Africa Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 277. Africa Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 278. Africa Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 279. North America Smoking Cessation Products, by Country USD Million (2025-2030)
  • Table 280. North America Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 281. North America Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 282. North America Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 283. United States Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 284. United States Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 285. United States Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 286. Canada Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 287. Canada Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 288. Canada Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 289. Mexico Smoking Cessation Products, by Type USD Million (2025-2030)
  • Table 290. Mexico Smoking Cessation Products, by Sales Channel USD Million (2025-2030)
  • Table 291. Mexico Smoking Cessation Products, by End User USD Million (2025-2030)
  • Table 292. Smoking Cessation Products Sales: by Type(K Units)
  • Table 293. Smoking Cessation Products Sales Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride , by Region K Units (2025-2030)
  • Table 294. Smoking Cessation Products Sales Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler) , by Region K Units (2025-2030)
  • Table 295. Smoking Cessation Products Sales E-Cigarette , by Region K Units (2025-2030)
  • Table 296. Smoking Cessation Products Sales: by Sales Channel(K Units)
  • Table 297. Smoking Cessation Products Sales Online Pharmacies , by Region K Units (2025-2030)
  • Table 298. Smoking Cessation Products Sales Hospital Pharmacies , by Region K Units (2025-2030)
  • Table 299. Smoking Cessation Products Sales Retail Pharmacies , by Region K Units (2025-2030)
  • Table 300. Smoking Cessation Products Sales: by End User(K Units)
  • Table 301. Smoking Cessation Products Sales Adults , by Region K Units (2025-2030)
  • Table 302. Smoking Cessation Products Sales Teenagers , by Region K Units (2025-2030)
  • Table 303. South America Smoking Cessation Products Sales, by Country K Units (2025-2030)
  • Table 304. South America Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 305. South America Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 306. South America Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 307. Brazil Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 308. Brazil Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 309. Brazil Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 310. Argentina Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 311. Argentina Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 312. Argentina Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 313. Rest of South America Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 314. Rest of South America Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 315. Rest of South America Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 316. Asia Pacific Smoking Cessation Products Sales, by Country K Units (2025-2030)
  • Table 317. Asia Pacific Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 318. Asia Pacific Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 319. Asia Pacific Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 320. China Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 321. China Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 322. China Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 323. Japan Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 324. Japan Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 325. Japan Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 326. India Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 327. India Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 328. India Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 329. South Korea Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 330. South Korea Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 331. South Korea Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 332. Taiwan Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 333. Taiwan Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 334. Taiwan Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 335. Australia Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 336. Australia Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 337. Australia Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 338. Rest of Asia-Pacific Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 339. Rest of Asia-Pacific Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 340. Rest of Asia-Pacific Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 341. Europe Smoking Cessation Products Sales, by Country K Units (2025-2030)
  • Table 342. Europe Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 343. Europe Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 344. Europe Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 345. Germany Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 346. Germany Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 347. Germany Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 348. France Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 349. France Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 350. France Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 351. Italy Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 352. Italy Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 353. Italy Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 354. United Kingdom Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 355. United Kingdom Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 356. United Kingdom Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 357. Netherlands Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 358. Netherlands Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 359. Netherlands Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 360. Rest of Europe Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 361. Rest of Europe Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 362. Rest of Europe Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 363. MEA Smoking Cessation Products Sales, by Country K Units (2025-2030)
  • Table 364. MEA Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 365. MEA Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 366. MEA Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 367. Middle East Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 368. Middle East Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 369. Middle East Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 370. Africa Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 371. Africa Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 372. Africa Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 373. North America Smoking Cessation Products Sales, by Country K Units (2025-2030)
  • Table 374. North America Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 375. North America Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 376. North America Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 377. United States Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 378. United States Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 379. United States Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 380. Canada Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 381. Canada Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 382. Canada Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 383. Mexico Smoking Cessation Products Sales, by Type K Units (2025-2030)
  • Table 384. Mexico Smoking Cessation Products Sales, by Sales Channel K Units (2025-2030)
  • Table 385. Mexico Smoking Cessation Products Sales, by End User K Units (2025-2030)
  • Table 386. Smoking Cessation Products: by Type(USD/Units)
  • Table 387. Research Programs/Design for This Report
  • Table 388. Key Data Information from Secondary Sources
  • Table 389. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Smoking Cessation Products: by Type USD Million (2018-2023)
  • Figure 5. Global Smoking Cessation Products: by Sales Channel USD Million (2018-2023)
  • Figure 6. Global Smoking Cessation Products: by End User USD Million (2018-2023)
  • Figure 7. South America Smoking Cessation Products Share (%), by Country
  • Figure 8. Asia Pacific Smoking Cessation Products Share (%), by Country
  • Figure 9. Europe Smoking Cessation Products Share (%), by Country
  • Figure 10. MEA Smoking Cessation Products Share (%), by Country
  • Figure 11. North America Smoking Cessation Products Share (%), by Country
  • Figure 12. Global Smoking Cessation Products: by Type K Units (2018-2023)
  • Figure 13. Global Smoking Cessation Products: by Sales Channel K Units (2018-2023)
  • Figure 14. Global Smoking Cessation Products: by End User K Units (2018-2023)
  • Figure 15. South America Smoking Cessation Products Share (%), by Country
  • Figure 16. Asia Pacific Smoking Cessation Products Share (%), by Country
  • Figure 17. Europe Smoking Cessation Products Share (%), by Country
  • Figure 18. MEA Smoking Cessation Products Share (%), by Country
  • Figure 19. North America Smoking Cessation Products Share (%), by Country
  • Figure 20. Global Smoking Cessation Products: by Type USD/Units (2018-2023)
  • Figure 21. Global Smoking Cessation Products share by Players 2023 (%)
  • Figure 22. Global Smoking Cessation Products share by Players (Top 3) 2023(%)
  • Figure 23. Global Smoking Cessation Products share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2023
  • Figure 27. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 31. Reynolds American, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Reynolds American, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Cipla Inc. (India) Revenue, Net Income and Gross profit
  • Figure 34. Cipla Inc. (India) Revenue: by Geography 2023
  • Figure 35. Imperial Brands (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Imperial Brands (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Perrigo Company plc, (Ireland) Revenue, Net Income and Gross profit
  • Figure 38. Perrigo Company plc, (Ireland) Revenue: by Geography 2023
  • Figure 39. Amarantus Bioscience Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Amarantus Bioscience Holdings, Inc. (United States) Revenue: by Geography 2023
  • Figure 41. Global Smoking Cessation Products: by Type USD Million (2025-2030)
  • Figure 42. Global Smoking Cessation Products: by Sales Channel USD Million (2025-2030)
  • Figure 43. Global Smoking Cessation Products: by End User USD Million (2025-2030)
  • Figure 44. South America Smoking Cessation Products Share (%), by Country
  • Figure 45. Asia Pacific Smoking Cessation Products Share (%), by Country
  • Figure 46. Europe Smoking Cessation Products Share (%), by Country
  • Figure 47. MEA Smoking Cessation Products Share (%), by Country
  • Figure 48. North America Smoking Cessation Products Share (%), by Country
  • Figure 49. Global Smoking Cessation Products: by Type K Units (2025-2030)
  • Figure 50. Global Smoking Cessation Products: by Sales Channel K Units (2025-2030)
  • Figure 51. Global Smoking Cessation Products: by End User K Units (2025-2030)
  • Figure 52. South America Smoking Cessation Products Share (%), by Country
  • Figure 53. Asia Pacific Smoking Cessation Products Share (%), by Country
  • Figure 54. Europe Smoking Cessation Products Share (%), by Country
  • Figure 55. MEA Smoking Cessation Products Share (%), by Country
  • Figure 56. North America Smoking Cessation Products Share (%), by Country
  • Figure 57. Global Smoking Cessation Products: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • GlaxoSmithKline plc (United Kingdom)
  • Pfizer Inc. (United States)
  • Johnson & Johnson (United States)
  • Reynolds American, Inc. (United States)
  • Cipla Inc. (India)
  • Imperial Brands (United Kingdom)
  • Perrigo Company plc, (Ireland)
  • Amarantus Bioscience Holdings, Inc. (United States)
Additional players considered in the study are as follows:
Takeda Consumer Healthcare Company Limited (Japan) , Kimree Technology Co.,Ltd. (China)
Select User Access Type

Key Highlights of Report


Nov 2024 215 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Smoking Cessation Products Market are by type [Non-Nicotine Products (Varenicline Tartrate and Buproprion Hydrochloride, Nicotine Products (Gum, Lozenge, Transdermal Patch, Nasal Spray, Oral Inhaler) and E-Cigarette], by end use application [].
The Smoking Cessation Products Market is gaining popularity and expected to see strong valuation by 2030.
  • The Growing Population Including Teenagers with Addiction to Smoking and Tobacco Leading to Higher Chances of Lungs Related Problems
  • Awareness about the Harmful Effects of Smoking Addiction and Desire to Quit Smoking

Know More About Global Smoking Cessation Products Report?